ADVERSE EVENTS ASSOCIATED WITH INFLIXIMAB THERAPY IN A LARGE SINGLE CENTRE UK COHORT

被引：0
|
作者：
Sprakes, M. [1 ]
Hamlin, P. J. [1 ]
Warren, L. [1 ]
Greer, D. [1 ]
Ford, A. C. [1 ]
机构：
[1] Leeds Gen Infirm, Leeds, W Yorkshire, England
来源：
GUT | 2011年 / 60卷
关键词：
adverse events; infliximab;
D O I：
10.1136/gut.2011.239301.459
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Immunotherapy and associated immune-related adverse events at a large UK centre: a mixed methods study
    Liz Jamieson
    Martin D. Forster
    Kam Zaki
    Sanjena Mithra
    Heena Alli
    Anne O’Connor
    Apini Patel
    Ian C. K. Wong
    Pinkie Chambers
    BMC Cancer, 20
  • [2] Immunotherapy and associated immune-related adverse events at a large UK centre: a mixed methods study
    Jamieson, Liz
    Forster, Martin D.
    Zaki, Kam
    Mithra, Sanjena
    Alli, Heena
    O'Connor, Anne
    Patel, Apini
    Wong, Ian C. K.
    Chambers, Pinkie
    BMC CANCER, 2020, 20 (01)
  • [3] Efficacy and safety of infliximab therapy in a large single centre UK population: The leeds immune mediated inflammatory disease centre experience
    Sprakes, M.
    Donnellan, C.
    Warren, L.
    Greer, D.
    Hamlin, J.
    GUT, 2008, 57 : A148 - A149
  • [4] PREDICTORS OF RESPONSE AND LOSS OF RESPONSE TO INFLIXIMAB THERAPY FOR CROHN'S DISEASE: A LARGE UK SINGLE CENTRE EXPERIENCE
    Sprakes, M.
    Ford, A. C.
    Warren, L.
    Greer, D.
    Hamlin, P. J.
    GUT, 2011, 60 : A218 - A218
  • [5] Pulmonary adverse events related to idelalisib therapy: A single centre experience
    Migault, Caroline
    Lebrun, Delphine
    Toubas, Olivier
    Nguyen, Yohan
    Giltat, Aurelien
    Julien, Gautier
    Toubas, Dominique
    Lebargy, Francois
    Delmer, Alain
    Bani-Sadr, Firouze
    JOURNAL OF CHEMOTHERAPY, 2018, 30 (05) : 318 - 322
  • [6] Disparity between infliximab trough level and infliximab associated adverse events
    Huang, V. W.
    Dhami, N.
    Fedorak, D. K.
    Prosser, C.
    Shalapay, C.
    Kroeker, K. I.
    Fedorak, R. N.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S282 - S282
  • [7] Infliximab Trough Levels Are Correlated With Infliximab-Associated Adverse Events
    Huang, Vivian
    Dhami, Neil
    Fedorak, Darryl K.
    Prosser, Connie
    Carol, Shalapay
    Kroeker, Karen I.
    Fedorak, Richard N.
    GASTROENTEROLOGY, 2014, 146 (05) : S1 - S1
  • [8] Efficacy and Tolerability of a Biosimilar Infliximab Switch - A Large Single-Centre Experience From the UK
    Bhandare, Anirudh Pramod
    Nigam, Gaurav Bhasker
    Nayeemudin, Shadab
    Limdi, Jimmy K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S380 - S380
  • [9] Adverse Events Associated With Meropenem Versus Imipenem/Cilastatin Therapy in a Large Retrospective Cohort of Hospitalized Infants
    Hornik, Christoph P.
    Herring, Amy H.
    Benjamin, Daniel K., Jr.
    Capparelli, Edmund V.
    Kearns, Gregory L.
    van den Anker, John
    Cohen-Wolkowiez, Michael
    Clark, Reese H.
    Smith, P. Brian
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (07) : 748 - 753
  • [10] Adverse diagnostic events in hospitalised patients: a single-centre, retrospective cohort study
    Dalal, Anuj K.
    Plombon, Savanna
    Konieczny, Kaitlyn
    Motta-Calderon, Daniel
    Malik, Maria
    Garber, Alison
    Lam, Alyssa
    Piniella, Nicholas
    Leeson, Marie
    Garabedian, Pamela
    Goyal, Abhishek
    Roulier, Stephanie
    Yoon, Cathy
    Fiskio, Julie M.
    Schnock, Kumiko O.
    Rozenblum, Ronen
    Griffin, Jacqueline
    Schnipper, Jeffrey L.
    Lipsitz, Stuart
    Bates, David W.
    BMJ QUALITY & SAFETY, 2024,
12345